Search

everythinglearnresearchcommunity

for

Search:↓

Starting 5-alpha reductase inhibitors does not significantly increase the risk of rhabdomyolysis in older men, but is linked to a higher risk of muscle conditions.

5-Alpha-Reductase inhibitors shorten COVID-19 recovery time in men.

Men taking 5-alpha reductase inhibitors for prostate issues may be less likely to experience severe COVID-19, but it doesn't prevent ICU admission or death.

Taking 5-alpha reductase inhibitors does not increase the risk of breast cancer in men.

Medications for hair loss and prostate issues can significantly increase the risk of sexual side effects and other negative symptoms.

The authors suggest that 5-α-reductase inhibitors, like dutasteride, are effective in treating frontal fibrosing alopecia and should be the first-line treatment, with other options for severe cases. They also recommend further research on Janus kinase inhibitors.

Taking 5-alpha reductase inhibitors does not increase breast cancer risk in men.

Dutasteride is cheaper than finasteride for treating benign prostatic hyperplasia.

Dutasteride and finasteride can help increase hair growth gene expression but need further improvement.

Medicines for enlarged prostate may raise the risk of breast growth and tenderness but not breast cancer.

5-alpha-reductase inhibitors help treat urinary symptoms from an enlarged prostate.

Alpha-blockers and 5-alpha reductase inhibitors don't significantly increase dementia risk.

Herbal drugs show promise for treating alopecia with fewer side effects, but standardization is challenging.

Using 5α-reductase inhibitors for hair loss in women doesn't increase cancer risk.

5-alpha reductase inhibitors may help protect the brain and gut in Parkinson's disease.

Finasteride and dutasteride do not significantly change beard thickness in men.

Men taking dutasteride may have a higher risk of age-related macular degeneration.

5-alpha-reductase inhibitors lower PSA density but higher PSA density indicates disease progression.

Finasteride and dutasteride are effective in treating male hair loss but can cause sexual side effects and birth defects.

5-Alpha Reductase Inhibitors are effective for male hair loss and some skin conditions, but their effectiveness in women and safety concerns require careful use.

PrEP doesn't increase STI risk in high-risk men, anti-androgen drugs may lower ICU admission for male COVID-19 patients, a 3-point injection is better for crow's feet, and the 'Geriatric-8' tool could help assess frailty in older skin cancer patients.

5-alpha reductase inhibitors slightly reduce urinary symptoms and may lower surgery and acute retention risks in men.

5-Alpha reductase inhibitors help treat enlarged prostate but may cause sexual side effects.

Long-term treatment with finasteride or combined therapy worsens sexual function in men with urinary issues.

5-alpha reductase inhibitors help treat prostate issues in aging men, but their role in cancer prevention is debated.

5ARIs effectively treat and manage BPH by reducing prostate size and symptoms.

Finasteride reduces prostate cancer risk but may increase high-grade tumors and has side effects; biopsy methods have similar outcomes; psychosocial factors affect sexual recovery post-surgery.

Using 5α-reductase inhibitors for hair loss can cause lasting sexual, physical, mental, and vascular health issues in men, even after stopping the medication.

Lower finasteride doses had more side effects; dutasteride caused back pain; more research needed on post-finasteride syndrome.

Finasteride and dutasteride, used for prostate issues and hair loss, can cause side effects like sexual dysfunction and mental issues, which may continue even after stopping the medication, a condition called post-finasteride syndrome, for which there's currently no cure.